Berui Pharmaceuticals: Intends to issue H shares and list on the main board of the Hong Kong Stock Exchange.

Bora Pharmaceutical announced that the company held the 12th meeting of the fourth board of directors and the 10th meeting of the fourth supervisors on September 26, 2025, and reviewed and approved the proposals including "Proposal on the issuance of H shares by the company and listing on the main board of Hong Kong Stock Exchange" and "Proposal on the issuance of H shares by the company and listing on the main board of Hong Kong Stock Exchange." The company plans to issue H shares and list on the main board of the Hong Kong Stock Exchange to accelerate its internationalization strategy, overseas business layout, strengthen overseas financing capabilities, and enhance capital strength and comprehensive competitiveness. The company will fully consider the interests of existing shareholders and the capital market situation, choose the appropriate timing and window to complete this issuance and listing. Specific details are yet to be determined, and there is significant uncertainty.